کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2514163 | 1118453 | 2008 | 8 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Bcl-2 family members as molecular targets in cancer therapy Bcl-2 family members as molecular targets in cancer therapy](/preview/png/2514163.png)
Escape from apoptosis is often a hallmark of cancer cells, and is associated to chemotherapy resistance or tumor relapse. Proteins from the Bcl-2 family are the key regulators of the intrinsic pathway of apoptosis, controlling the point-of no-return and setting the threshold to engage the death machinery in response to a chemical damage. Therefore, Bcl-2 proteins have emerged as an attractive target to develop novel anticancer drugs. Current pharmacological approaches are focused on the use of peptides, small inhibitory molecules or antisense oligonucleotides to neutralize antiapoptotic Bcl-2 proteins, lowering the threshold and facilitating apoptosis of cancer cells. We discuss here recent advances in the development of Bcl-2 targeted anticancer therapies.
Journal: Biochemical Pharmacology - Volume 76, Issue 8, 15 October 2008, Pages 939–946